24小时热门版块排行榜    

查看: 1499  |  回复: 7
【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 学员JYzuYE 的 10 个金币

zwjxyzcl

铁虫 (初入文坛)

[交流] JMCC reject&resubmission大家帮忙看看

投心血管的JMCC 结果被reject&resubmission,编辑好像没提出什么意见。审稿人的意见感觉分歧很大啊,review1感觉并没有细看文章 连对我文章的描述都错了2处。而后2个审稿人意见还比较不错,几乎不需要补实验,只是要润色文章 答答问题。因为review1的意见改起来估计都可以发篇SCI了(见过一篇5分的文章做过上游),可能无法修改,而且我感觉他对我们有些偏见,怕是怎么改都没用。。。。请战友们分析下,重投中的可能性大么。。。。会不会换个审稿人呢,以下附审稿意见:
Reviewer #1: The authorstried to show the involvement of mir-145 for CD-137 induced migration ofvascular smooth muscle cells. The concept is too complex and data qualityis not good. Composition of manuscript is not good. Manuscript included the manyof type-miss, mixed with some non-english characters.
1) Authors mentioned CD-137 down-regulate mir145, which leaded to down regulation of NFATc1 but In Fig 2A the expression ofNFATc1 with CD137 is very small. Data quality is not generally good, thus, I donot recommend the manuscript for publication.
Reviewer #2: Yan et alshowed that CD137 accelerated neointima formation and VSMCs proliferation andmigration in vivo and in vitro. Mechanistically, miR145 was downregulated andresulted in increased NFATc1 expression in VSMCs upon treatment with agonisticCD137 antibody. To investigate why VSMCs phenotype transformed, the authorsshowed that overexpression of miR145 or NFATc1 deficiency could rescue the VSMCtransformation led by CD137. This is a well design and performed manuscript.There will be interesting for the readers of JMCC. However, this manuscript canbe strengthened with the following revision:
Major comments
Reviewer #3: The study byYan et al. showed that CD137, a protein belonging to the TNF superfamily,induces vascular smooth muscle cell dedifferentiation through down regulatingmiR-145 and up-regulating NFATc1. Previously many reports showed that miR-145could modulate the fate of smooth muscle cells In this study, the authorsshowed that miR-145 targets NFATc1 mRNA to reduces its expression, which is anovel finding. In general, the study design is logic and the data aresupporting the hypothesis. However, there are multiple issues with the study:
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
2楼2015-06-14 16:22:31
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

listensea8318

铁杆木虫 (知名作家)

😊😊

[ 发自手机版 https://muchong.com/3g ]
这个时代论文还是管用的!!!
3楼2015-06-14 16:55:55
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

WolfYang

至尊木虫 (职业作家)


小木虫: 金币+0.5, 给个红包,谢谢回帖
你先按审稿2和3的意见修改,审稿人1的意见 能修改就改,不能的话,写份详细理由说明转交给reviewer 1。其实如果有两个正意见就可以,我想这就是编辑让你重投的原因,他只是不认可你当前版本的论文,多花的时间好好改,应该能接受的。一定要认真对待其他两个审稿人意见!

[ 发自手机版 https://muchong.com/3g ]
4楼2015-06-14 19:03:33
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

ljq158

至尊木虫 (知名作家)


小木虫: 金币+0.5, 给个红包,谢谢回帖
希望很大,However,如果编辑重新找审稿人就难说,以前就遇到过 reject and resubmission,意见返回去,编辑没送原来审稿人,而是重新找了更严格的审稿人,结果被拒。
5楼2015-06-14 19:29:16
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zwjxyzcl

铁虫 (初入文坛)

问下哈 这种reject&resubmission是不是很常见啊?给人感觉很多人都遇到过
6楼2015-06-17 20:33:29
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

XDxiaohu

木虫 (知名作家)


小木虫: 金币+0.5, 给个红包,谢谢回帖
好好改,然后重投就是了~~祝好~
西藏--与神耳语的地方
7楼2015-06-17 21:04:49
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zwjxyzcl

铁虫 (初入文坛)

引用回帖:
7楼: Originally posted by XDxiaohu at 2015-06-17 21:04:49
好好改,然后重投就是了~~祝好~

嗯嗯 如果侥幸投上了一定来这还愿
8楼2015-06-18 16:19:28
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 学员JYzuYE 的主题更新
普通表情 高级回复(可上传附件)
信息提示
请填处理意见